Profile of patients with cryptococcosis in a regional hospital in the interior of São Paulo
Keywords:HIV; Death; Relative Risk; Cryptococcosis; Odds ratio.
Infections caused by Cryptococus spp. are opportunistic, urban, and associated with immunosuppression. Mortality is estimated at 10% in developed countries and 43% in emerging countries. The objective was to evaluate the clinical-epidemiological aspects of cryptococcosis in the region of western São Paulo. This is a cross-sectional study, based on information from the medical records of patients in a hospital in the interior of São Paulo from 2006 to 2018. Descriptive analysis was applied through absolute (n) and relative (%) frequency; and statistics through the x2 and Fisher's Exact tests. Relative Risk (RR) and Odds Ratio (OD) for death were also calculated. Neurocriptococcosis was the primary clinical manifestation of 64.50%. The direct search for CSF was positive in 85.71% of the samples, the immunodiagnosis in 93.80% and the culture, gold standard for fungus, in 55.55% of the cases. The x2 test and Fisher's exact test showed no difference between sex, age group, clinical form of death. RR and OD were considered low. The association of the epidemiological aspects of cryptococcosis with its clinical signs allows the early diagnosis of the disease, reducing severe conditions. Besides, high-performance antiretroviral therapies have dramatically decreased the occurrence of deaths in patients with HIV.
Acheson, E. S., Galanis, E., Bartlett, K., Mak, S., & Klinkenberg, B. (2018). Searching for clues for eighteen years: Deciphering the ecological determinants of Cryptococcus gattii on Vancouver Island, British Columbia. Medical Mycology, 56(2), 129–144. doi:10.1093/mmy/myx037
Andrade-Silva, L. E., Ferreira-Paim, K., Ferreira, T. B., Vilas-Boas, A., Mora, D. J., Manzato, V. M., Fonseca, [..], & Silva-Vergara, M. L. (2018). Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors. PloS one, 13(3), 82 p. doi:10.1371/journal.pone.0193237
Bastos A. L. (2017). Aspectos clínicos-epidemiológicos da criptococose no estado de Goiás. Dissertação de Mestrado em Ciências da Saúde, Universidade Federal de Goiás – UFG, Goiânia, Brasil.
Brazilian Society of Tropical Medicine. Guidelines in cryptococcosis-2008. (2008). Rev. Soc. Bras. Med. Trop, 41(5), 524-544. doi:10.1590/S0037-86822008000500022
Candiani, T. M. S., Pinto, J., Cardoso, C. A. A., Carvalho, I. R., Dias, A. C. M., Carneiro, M., & Goulart, E. A. (2007). Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte, Minas Gerais State, Brazil. Cadernos de Saúde Pública, 23 (Suppl. 3), S414-S423. doi:10.1590/S0102-311X2007001500009
Colombo, G., Táparo, C. V., Araújo Júnior, E. C., Makatu, M. Y., Santos, F. S., & Marinho, M. (2015). Caracterização bioquímica e molecular de Cryptococcus spp. isolados de excretas ambientais de pombos (Columba livia domestica). Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 67(6), 1639-1645. doi:10.1590/1678-4162-7753
Hurtado, J. C., Castillo, P., Fernandes, F., Navarro, M., Lovane, L., [..], & Casas, I. (2019). Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study. Scientific reports, 9(1): 1-10. doi:10.1038/s41598-019-43941-w
Maziarz, E. K., & Perfect, J. R. (2016). Cryptococcosis. Infectious disease clinics of North America, 30(1), 179–206. doi:10.1016/j.idc.2015.10.006
Mourad, A., & Perfect, J. R. (2018). Present and Future Therapy of Cryptococcus. Infections. Journal of fungi, 4(3), 79. doi:10.3390/jof4030079
Nunes, A. A., Caliani, L. S., Nunes, M. S., Silva, A. S., & Mello, L. M. (2015). Análise do perfil de pacientes com HIV/Aids hospitalizados após introdução da terapia antirretroviral (HAART). Ciência & Saúde Coletiva, 20(10), 3191-3198. doi:10.1590/1413-812320152010.03062015
Skipper, C., Abassi, M., & Boulware, D. R. (2019). Diagnosis and Management of Central Nervous System Cryptococcal Infections in HIV-Infected Adults. Journal of fungi (Basel, Switzerland), 5(3), 65-76. doi:10.3390/jof5030065
Spadari, C. C, Wirth, F., Lopes, L. B, & Ishida, K. (2020). Novas abordagens para o tratamento de criptococose. Microorganismos, 8 (4), 613. doi:10.3390/microorganisms8040613
Secretaria de Saúde do Estado de Goiás - SUVISA. (2012). Micoses Sistêmicas. Retirado de: https://www.saude.go.gov.br/sesg/comissao-de-integracao-ensino-servico/337-suvisa/7428-micoses-sist.
WHO, World Health Organization. (2018). The diagnosis, prevention and management of cryptococcal disease in hiv-infected adults, adolescents and children. Retirado de: https://www.who.int/hiv/pub/guidelines/cryptococcal-disease/en/.
Zaragoza, O. (2019). Basic principles of the virulence of Cryptococcus. Virulence, 10(1), 490–501. doi:10.1080/21505594.2019.1614383
How to Cite
Copyright (c) 2020 Maikiane Aparecida Nascimento; Elorraine Coutinho Mathias Santos; Valéria Moura de Carvalho; Marielly Sousa Borges; João Pedro Brambilla Ederli; Camila Aparecida Nunes de Albuquerque; Savyla Franciele Soares Silva; Rosana Brambilla Ederli; Bruno Alexandre Soto Soto; Alexandre Martins Portelinha Filho; Daniela Vanessa Moris
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.